|
Market Closed -
Nasdaq
21:00:00 21/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 37.18 USD | +1.47% |
|
+23.07% | +36.59% |
| 07-30 | Agios Pharmaceuticals, Inc., Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-30 | Agios Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 2.19B 1.95B 1.8B 1.63B 3.08B 206B 3.11B 21.64B 8.49B 109B 8.21B 8.04B 346B | P/E 2026 * |
-6.38x | P/E 2027 * | -9.8x |
|---|---|---|---|---|---|
| Enterprise Value | 2.05B 1.83B 1.69B 1.53B 2.89B 194B 2.92B 20.32B 7.97B 102B 7.71B 7.54B 325B | EV / Sales 2026 * |
11.5x | EV / Sales 2027 * | 6.25x |
| Free-Float |
77.8% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AGIO | Delayed | |
CBOE
| AGIO | Real-time | |
|
Tradegate
| 8AP | Real-time | |
|
Boerse Muenchen
| 8AP | Real-time | |
|
Deutsche Boerse AG
| 8AP | Delayed | |
|
Börse Stuttgart
| 8AP | Delayed | |
|
Berne S.E.
| 8AP | End-of-day quote |
Last Transcript: Agios Pharmaceuticals, Inc.
| 1 day | +1.47% | ||
| 1 week | +23.07% | ||
| Current month | +11.82% | ||
| 1 month | +12.43% | ||
| 3 months | -7.19% | ||
| 6 months | +37.35% | ||
| Current year | +36.59% |
| 1 week | 31.16 |  | 37.58 |
| 1 month | 29.67 | | 37.58 |
| Current year | 24.29 | | 44.09 |
| 1 year | 22.24 | | 46 |
| 3 years | 19.8 | | 62.58 |
| 5 years | 16.75 | | 62.58 |
| 10 years | 16.75 | | 99.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Goff
CEO | Chief Executive Officer | 57 | 07/08/2022 |
Cecilia Jones
DFI | Director of Finance/CFO | 51 | 25/09/2022 |
Sarah Gheuens
CTO | Chief Tech/Sci/R&D Officer | 47 | 31/08/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 66 | 08/12/2014 | |
May Kin Ho
BRD | Director/Board Member | 73 | 22/06/2015 |
David Scadden
BRD | Director/Board Member | 73 | 26/05/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/08/26 | Sell | Chief Technology Officer | -30,000 | 0.0504% | ||
| 08/07/26 | Free | Director | 2,894 | 0.0049% | ||
| 01/07/26 | Exercice | Chief Technology Officer | 20,757 | 0.0349% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.47% | +23.07% | -12.83% | +73.90% | 2.19B | |
| -0.21% | -6.36% | +49.00% | +74.13% | 66.34B | |
| -0.22% | +10.10% | +12.77% | +87.32% | 52.92B | |
| +0.82% | +9.46% | +7.75% | +73.53% | 54.82B | |
| +3.28% | +6.12% | +30.46% | +50.05% | 44.09B | |
| +0.51% | +10.71% | +21.30% | +133.92% | 43.72B | |
| -1.15% | +3.10% | +259.71% | +594.60% | 42.13B | |
| +0.10% | +9.96% | +17.15% | +59.33% | 33.96B | |
| -1.30% | -3.61% | +37.37% | +7.16% | 26.17B | |
| +0.69% | +6.07% | +31.89% | +26.94% | 23.37B | |
| Average | +0.51% | +6.43% | +45.46% | +118.09% | 38.97B | |
| Weighted average by Cap. | +0.44% | +4.76% | +50.92% | +127.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 178M 159M 147M 133M 250M 16.8B 253M 1.76B 691M 8.83B 668M 654M 28.14B | 347M 309M 286M 259M 488M 32.75B 494M 3.43B 1.35B 17.22B 1.3B 1.27B 54.86B |
| Net income | -342M -305M -282M -255M -481M -32.27B -487M -3.38B -1.33B -16.96B -1.28B -1.26B -54.05B | -233M -207M -192M -174M -327M -21.95B -331M -2.3B -903M -11.54B -873M -855M -36.77B |
| Net Debt | -133M -119M -110M -99.62M -188M -12.59B -190M -1.32B -518M -6.62B -501M -490M -21.09B | -18.27M -16.28M -15.07M -13.64M -25.7M -1.72B -26.01M -181M -70.92M -906M -68.54M -67.11M -2.89B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/10/26 | US$37.18 | +1.47% | 849,792 |
| 20/10/26 | US$36.64 | +4.99% | 1,518,815 |
| 19/10/26 | US$34.90 | +11.43% | 1,973,686 |
| 16/10/26 | US$31.32 | -3.09% | 952,684 |
| 15/10/26 | US$32.32 | +4.36% | 2,048,391 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AGIO Stock
Select your edition
All financial news and data tailored to specific country editions
